
Jordi Mones, MD, PhD, discusses what is believed to be the first direct-to-phase 2 trial testing an optogenetic gene therapy to restore vision lost to GA.

Jordi Monés, MD, PhD, is director of Institut de la Màcula in Barcelona, Spain, and adjunct professor at the John A. Moran Eye Center, University of Utah in Salt Lake City.